The Priority Review

Tag

Iptacopan

1 story

Stories

  1. Clinical trials

    Novartis registers Phase 3b roll-over extension study of iptacopan

    The study plans to enroll 36 participants and is scheduled to start on November 16, 2026. It aims to assess the long-term safety, tolerability, and efficacy of iptacopan in patients with complement mediated diseases.